NEW YORK (TheStreet) -- BG Medicine  (BGMD) plunged Wednesday after the diagnostics company reported first-quarter results that came up short of analysts' expectations.

The company reported a loss of 8 cents a share, which aligned with the estimate of a loss of 8 cents a share. Revenue totaled $739,000, which came up short of the estimate of $1.3 million.

The stock was down 15.75% to $1.07 at 1:46 p.m.

Must Read: Warren Buffett's 10 Favorite Growth Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BGMD Chart

BGMD data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.